edoc

Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening

Paradiso, Viola and Garofoli, Andrea and Tosti, Nadia and Lanzafame, Manuela and Perrina, Valeria and Quagliata, Luca and Matter, Matthias S. and Wieland, Stefan and Heim, Markus H. and Piscuoglio, Salvatore and Ng, Charlotte K. Y. and Terracciano, Luigi M.. (2018) Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening. The Journal of molecular diagnostics : JMD, 20 (6). pp. 836-848.

[img] PDF - Accepted Version
Restricted to Repository staff only until 23 August 2019.

4Mb

Official URL: https://edoc.unibas.ch/68131/

Downloads: Statistics Overview

Abstract

Commercially available targeted panels miss genomic regions frequently altered in hepatocellular carcinoma (HCC). We sought to design and benchmark a sequencing assay for genomic screening of HCC. We designed an AmpliSeq custom panel targeting all exons of 33 protein-coding and two long noncoding RNA genes frequently mutated in HCC, TERT promoter, and nine genes with frequent copy number alterations. By using this panel, the profiling of DNA from fresh-frozen (n = 10, 1495×) and/or formalin-fixed, paraffin-embedded (FFPE) tumors with low-input DNA (n = 36, 530×) from 39 HCCs identified at least one somatic mutation in 90% of the cases. Median of 2.5 (range, 0 to 74) and 3 (range, 0 to 76) mutations were identified in fresh-frozen and FFPE tumors, respectively. Benchmarked against the mutations identified from Illumina whole-exome sequencing (WES) of the corresponding fresh-frozen tumors (105×), 98% (61 of 62) and 100% (104 of 104) of the mutations from WES were detected in the 10 fresh-frozen tumors and the 36 FFPE tumors, respectively, using the HCC panel. In addition, 18 and 70 somatic mutations in coding and noncoding genes, respectively, not found by WES were identified by using our HCC panel. Copy number alterations between WES and our HCC panel showed an overall concordance of 86%. In conclusion, we established a cost-effective assay for the detection of genomic alterations in HCC.
Faculties and Departments:03 Faculty of Medicine
03 Faculty of Medicine > Bereich Querschnittsfächer (Klinik) > Pathologie USB
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Querschnittsfächer (Klinik) > Pathologie USB
UniBasel Contributors:Piscuoglio, Salvatore
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Elsevier
ISSN:1943-7811
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Identification Number:
Last Modified:12 Feb 2019 09:32
Deposited On:25 Jan 2019 10:07

Repository Staff Only: item control page